0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Dapsone Hepatitis

William A. Lawrence, MD; Harvey W. Olsen, MD; Dean J. Nickles, MD
Arch Intern Med. 1987;147(1):175. doi:10.1001/archinte.1987.00370010173037.
Text Size: A A A
Published online

To the Editor.  —The excellent article "Liver Involvement in the Sulfone Syndrome" in the May 1986 issue of the Archives contains a case report of "dapsone hepatitis" that appears virtually identical to a case we treated in March 1986. Because of the rarity of this drug reaction, we are prompted to report this case.

Report of a Case.  —A 19-year-old woman developed dermatitis herpetiformis. She was treated with dapsone (50 mg/d, increasing to 150 mg/d). She stopped the drug therapy after a total of 17 days because the "rash was worse." Seven days later, the patient developed fever, malaise, chills, and anorexia. Three days later, she was hospitalized with jaundice, a temperature of 40.5°C (105°F), and biochemical evidence of hepatitis and hemolytic anemia. The patient was treated with methylprednisolone sodium succinate (40 mg intravenously every eight hours) starting on the first day of hospitalization. Dapsone therapy did not improve the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();